Morgan Stanley Bullish on Medtech in 2025, Upgrades 5 Stocks

Seeking Alpha12/03 05:12

Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos

Benzinga12/03 03:29

Morgan Stanley Upgrades Embecta to Equalweight, Price Target Is $20

MT Newswires12/02 20:48

Is It Time To Consider Buying Embecta Corp. (NASDAQ:EMBC)?

Yahoo Finance11/29 20:31

This Dick's Sporting Goods Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday

Benzinga11/28 00:18

Embecta Raised to Buy From Neutral by BTIG

Dow Jones11/27 20:42